Condition: Coronary Artery Disease · Sponsor: North Karelia Central Hospital
The purpose of this study is to compare DCB with DES in stable CAD or ACS patients who are at high risk of bleeding. The hypothesis of the DEBATE trial is that the strategy using DCB and a shorter DAPT regimen is non-inferior to the treatment using DES and longer DAPT duration on patients with high bleeding risk. If non-inferiority is shown, the superiority of the DCB strategy over DES strategy will be tested.
This description comes directly from the study's public registry record.
Tuomas Rissanen, MD, PhD · +358505998022 · tuomas.rissanen@siunsote.fi
Alma Räsänen, MD · alma.rasanen@siunsote.fi
Always discuss trial participation with your own doctor first.
| Central Hospital of Central Finland | Jyväskylä, Central Finland, Finland | Not Yet Recruiting |
| Central Hospital of Lapland | Rovaniemi, Lapland, Finland | Not Yet Recruiting |
| Kuopio University Hospital | Kuopio, Northern Savonia, Finland | Not Yet Recruiting |
| Turku University Hospital | Turku, Southwest Finland, Finland | Not Yet Recruiting |
| Helsinki University Hospital | Helsinki, Uusimaa, Finland | Not Yet Recruiting |
| North Karelia Central Hospital | Joensuu, Finland | Recruiting |
| Central Hospital of Päijät-Häme | Lahti, Finland | Recruiting |
| Oulu university hospital | Oulu, Finland | Not Yet Recruiting |
| Satakunta Central Hospital | Pori, Finland | Not Yet Recruiting |
| Tampere Heart Hospital | Tampere, Finland | Not Yet Recruiting |
| Centre Hospitalier La Rochelle | La Rochelle, France | Not Yet Recruiting |
| University Hospital of Carl Gustav Carus | Dresden, Germany | Not Yet Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04814212